Literature DB >> 14705494

A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents.

Cindi Holt Bedell1.   

Abstract

The development of numerous oral chemotherapy agents has led to a new paradigm in cancer treatment. Oral chemotherapy can be self-administered conveniently, so patients with cancer can receive their treatments in their homes instead of in a supervised and controlled healthcare environment. Cancer now is recognized as a treatable chronic disease, and new oral chemotherapy agents have been developed that offer targeted cancer treatment. Although the newer oral chemotherapy agents offer additional treatment options, they also pose challenges for patients and healthcare providers. Patient adherence and monitoring can be challenging, and reimbursement issues abound. Oncology nurses play a key role in assessing, educating, and monitoring patients receiving oral chemotherapy. In addition, they may be involved in assisting patients with obtaining reimbursement and, in some cases, may be instrumental in locating patient assistance programs. This article discusses patient care issues related to treatment with oral chemotherapy agents and provides a historical overview of their development and use.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14705494     DOI: 10.1188/03.CJON.S6.5-9

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  30 in total

Review 1.  Interventions to promote adherence with oral agents.

Authors:  Susan M Schneider; Kimberly Hess; Tracy Gosselin
Journal:  Semin Oncol Nurs       Date:  2011-05       Impact factor: 2.315

2.  Synthesis and biological evaluation of 2-amino-1-thiazolyl imidazoles as orally active anticancer agents.

Authors:  Wen-Tai Li; Der-Ren Hwang; Jen-Shin Song; Ching-Ping Chen; Tung-Wei Chen; Chi-Hung Lin; Jiunn-Jye Chuu; Tzu-Wen Lien; Tsu-An Hsu; Chen-Lung Huang; Huan-Yi Tseng; Chu-Chung Lin; Heng-Liang Lin; Chung-Ming Chang; Yu-Sheng Chao; Chiung-Tong Chen
Journal:  Invest New Drugs       Date:  2010-10-02       Impact factor: 3.850

3.  Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment in Turkey.

Authors:  Sultan Kav; Humeyra Bostanci
Journal:  Support Care Cancer       Date:  2006-06-07       Impact factor: 3.603

4.  Oral chemotherapy safety practices at US cancer centres: questionnaire survey.

Authors:  Saul N Weingart; Jonathan Flug; Daniela Brouillard; Laurinda Morway; Ann Partridge; Sylvia Bartel; Lawrence N Shulman; Maureen Connor
Journal:  BMJ       Date:  2007-01-12

5.  Patient and provider perspectives on delivery of oral cancer therapies.

Authors:  Caitlin C Murphy; Simon J Craddock Lee; David E Gerber; John V Cox; Hannah M Fullington; Robin T Higashi
Journal:  Patient Educ Couns       Date:  2019-06-20

Review 6.  Optimizing cancer care through mobile health.

Authors:  Bassel Odeh; Reem Kayyali; Shereen Nabhani-Gebara; Nada Philip
Journal:  Support Care Cancer       Date:  2015-02-04       Impact factor: 3.603

Review 7.  Oral Chemotherapy in Patients with Hematological Malignancies-Care Process, Pharmacoeconomic and Policy Implications.

Authors:  Jeffrey Betcher; Elizabeth Dow; Nandita Khera
Journal:  Curr Hematol Malig Rep       Date:  2016-08       Impact factor: 3.952

8.  Impact of anxio-depressive symptoms and cognitive function on oral anticancer therapies adherence.

Authors:  Mélanie Dos Santos; M Lange; R Gervais; B Clarisse; A Capel; M Barillet; J M Grellard; N Heutte; I Licaj; F Joly
Journal:  Support Care Cancer       Date:  2019-01-28       Impact factor: 3.603

9.  How Variable Is Our Delivery of Information? Approaches to Patient Education About Oral Chemotherapy in the Pediatric Oncology Clinic.

Authors:  Justine M Kahn; Uma H Athale; Luis A Clavell; Peter D Cole; Jean-Marie Leclerc; Caroline Laverdiere; Bruno Michon; Marshall A Schorin; Jennifer J G Welch; Stephen E Sallan; Lewis B Silverman; Kara M Kelly
Journal:  J Pediatr Health Care       Date:  2016-07-25       Impact factor: 1.812

Review 10.  Oral antineoplastic agents: how do we care about adherence?

Authors:  Marie Barillet; Virginie Prevost; Florence Joly; Bénédicte Clarisse
Journal:  Br J Clin Pharmacol       Date:  2015-10-28       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.